Subcutaneous ICD therapy results in a similar quality of life compared with transvenous ICD therapy during both short- and long-term follow-up

Back

EHRA Premium Access

Subcutaneous ICD therapy results in a similar quality of life compared with transvenous ICD therapy during both short- and long-term follow-up

Session: Device Therapy - ICD

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Ms J. De Veld (Amsterdam, NL)

Event: EHRA 2023

Congress Presentation

Add to my library

About the speaker

Ms Jolien Anne De Veld

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

0 follower

8 more presentations in this session

ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome

Speaker: Doctor T. Kleemann (Ludwigshafen, DE)

Access

Abstract

Slides

Automatic subcutaneous defibrillator screening in patients with intracardiac devices: comparative study depending on the point of pacing

Speaker: Doctor E. Cabrera Borrego (Granada, ES)

Access

Abstract

Slides

A manual synchronous low energy shock impedance as a predictor of successful defibrillation testing during subcutaneous icd implantation.

Speaker: Doctor C. Lopez Perales (Zaragoza, ES)

Access

Abstract

Slides

Clinical predictors of very low defibrillation threshold in the extravascular ICD

Speaker: Doctor F. Murgatroyd (London, GB)

Access

Abstract

Slides

The last shall be the first: the role of combined QLV- and CMR-determined electromechanical concordance in predicting optimal left ventricular stimulation site in cardiac resynchronisation therapy.

Speaker: Doctor M. Bertelli (Bologna, IT)

Access

Abstract

Slides

Access the full session

Device Therapy - ICD

Speakers: Ms J. De Veld, Doctor T. Kleemann, Doctor E. Cabrera Borrego, Doctor C. Lopez Perales, Doctor F. Murgatroyd...

Access

About the event

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources